Clinical trial

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

NCT02290028

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2014-12-16

PhaseNA

Study timeline

Study start (actual)2014-12-16Date precision: day

Registry last updated2021-03-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Sentus QP left ventricular leadDEVICE

Sponsors & collaborators

Biotronik SE & Co. KGlead sponsor

Biotronik, Inc.collaborator

Mapped research locations

New YorkNew York, United States4 BerlinGermany3 St LouisMissouri, United States2 ColumbusOhio, United States2 OrlandoFlorida, United States2 Winston-SalemNorth Carolina, United States2 LexingtonKentucky, United States2 DüsseldorfGermany2 BostonMassachusetts, United States1 ChicagoIllinois, United States1 PhiladelphiaPennsylvania, United States1 AtlantaGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02290028 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.